Trypanosomatid Diseases 2013
DOI: 10.1002/9783527670383.ch16
|View full text |Cite
|
Sign up to set email alerts
|

Drug Targets in Trypanosomal and Leishmanial Pentose Phosphate Pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
23
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(23 citation statements)
references
References 65 publications
0
23
0
Order By: Relevance
“…1) is the first enzyme of the oxidative branch of PPP, catalysing the oxidation of G6P to 6-phosphogluconolactone (6PGL) as NADP+ is reduced to NADPH (reviewed in [246]). This enzyme shares approximately 50% identity to its human homologue [247]. It localises mostly to the cytosol, although there is a small fraction compartimentalized in the glycosomes, although a typical peroxisomal targeting sequence (PTS) is absent [248,249].…”
Section: Oxidative Branchmentioning
confidence: 99%
See 4 more Smart Citations
“…1) is the first enzyme of the oxidative branch of PPP, catalysing the oxidation of G6P to 6-phosphogluconolactone (6PGL) as NADP+ is reduced to NADPH (reviewed in [246]). This enzyme shares approximately 50% identity to its human homologue [247]. It localises mostly to the cytosol, although there is a small fraction compartimentalized in the glycosomes, although a typical peroxisomal targeting sequence (PTS) is absent [248,249].…”
Section: Oxidative Branchmentioning
confidence: 99%
“…Therefore, 6PGL may have a detrimental role to prevent the accumulation of this PPP intermediate. However, its essentiality has not been addressed in any trypanosomatid [247].…”
Section: Oxidative Branchmentioning
confidence: 99%
See 3 more Smart Citations